Developing small molecule PTP4A3 inhibitors for ovarian cancer
Ended Project Grant Awarded Last action
- Award ID
- R43CA228774
- Recipient
-
Kevirx Inc. UEI UYB4K2ZUBD18
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $289,307
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Charlottesville, VA, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $289,307 |
Quick answers
Who received award R43CA228774?
R43CA228774 was awarded to Kevirx Inc. by National Cancer Institute (National Institutes of Health) on June 1, 2019.
How much is award R43CA228774 worth?
$289,307 has been obligated on R43CA228774.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award